SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN)

Q: What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in Q1 2025?

289 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 868459108

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 57,572,193
Total 13F shares: 59,101,687
Share change: -352,635
Total reported value: $1,935,404,930
Put/Call ratio: 72%
Price per share: $32.75
Number of holders: 289
Value change: -$15,482,554
Number of buys: 141
Number of sells: 128

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q1 2025

As of 31 Mar 2025, SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by 289 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,101,687 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, Stephens Investment Management Group LLC, RENAISSANCE TECHNOLOGIES LLC, LOOMIS SAYLES & CO L P, and GW&K Investment Management, LLC. This page lists 289 institutional shareholders reporting positions in this security for the Q1 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.